Education
About Us
Working with TipRanks
Follow Us
Hims & Hers Health, Inc. (HIMS)
NYSE:HIMS
HIMS Stock Chart & Stats
$27.09
-$0.61(-2.20%)
At close: 4:00 PM EST
$27.09
-$0.61(-2.20%)
Day’s Range― - ―
52-Week Range$23.97 - $72.98
Previous CloseN/A
Volume4.28M
Average Volume (3M)13.72M
Market Cap
$6.17B
Enterprise Value$6.71B
Total Cash (Recent Filing)$629.74M
Total Debt (Recent Filing)$1.12B
Price to Earnings (P/E)50.1
Beta2.66
Next Earnings
Mar 02, 2026EPS Estimate
0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.06
Shares Outstanding219,270,890
10 Day Avg. Volume16,102,511
30 Day Avg. Volume13,722,661
Financial Highlights & Ratios
PEG Ratio-0.07
Price to Book (P/B)10.95
Price to Sales (P/S)3.54
P/FCF Ratio26.33
Enterprise Value/Market Cap1.09
Enterprise Value/Revenue3.04
Enterprise Value/Gross Profit4.05
Enterprise Value/Ebitda42.51
Forecast
1Y Price Target
$39.75Price Target Upside46.73% Upside
Rating ConsensusHold
Number of Analyst Covering11
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Capital AllocationBoard authorization of a share repurchase program up to $250 million signals capital-return discipline and could support per-share value.
Expansion And Product DiversificationExpansion into new product categories and international markets could unlock scalable revenue streams if investments translate into stronger customer uptake and sales leverage.
Vertical Integration And Lab TestingAcquisition of YourBio Health strengthens at-home lab testing capabilities and brings experienced executives, supporting a vertically integrated consumer experience that can drive downstream medical prescriptions.
Bears Say
Demand And E-commerce TrendsDeclining order volumes and reduced app downloads indicate near-term revenue risk from softer online demand and weaker customer acquisition.
Execution And Operational MomentumInconsistent execution and shortfalls in core growth undermine operational momentum and heighten execution risk for future performance.
Margin And Competitive PressureSignificant investment spending combined with intensified competition in weight-loss and men's sexual health categories may compress margins and make consensus revenue targets harder to achieve.
Hims & Hers Health News
HIMS FAQ
What was Hims & Hers Health, Inc.’s price range in the past 12 months?
Hims & Hers Health, Inc. lowest stock price was $23.97 and its highest was $72.98 in the past 12 months.
What is Hims & Hers Health, Inc.’s market cap?
Hims & Hers Health, Inc.’s market cap is $6.17B.
When is Hims & Hers Health, Inc.’s upcoming earnings report date?
Hims & Hers Health, Inc.’s upcoming earnings report date is Mar 02, 2026 which is in 28 days.
How were Hims & Hers Health, Inc.’s earnings last quarter?
Hims & Hers Health, Inc. released its earnings results on Nov 03, 2025. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.094 by -$0.034.
Is Hims & Hers Health, Inc. overvalued?
According to Wall Street analysts Hims & Hers Health, Inc.’s price is currently Undervalued.
Does Hims & Hers Health, Inc. pay dividends?
Hims & Hers Health, Inc. does not currently pay dividends.
What is Hims & Hers Health, Inc.’s EPS estimate?
Hims & Hers Health, Inc.’s EPS estimate is 0.05.
How many shares outstanding does Hims & Hers Health, Inc. have?
Hims & Hers Health, Inc. has 219,270,890 shares outstanding.
What happened to Hims & Hers Health, Inc.’s price movement after its last earnings report?
Hims & Hers Health, Inc. reported an EPS of $0.06 in its last earnings report, missing expectations of $0.094. Following the earnings report the stock price went down -3.604%.
Which hedge fund is a major shareholder of Hims & Hers Health, Inc.?
Currently, no hedge funds are holding shares in HIMS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Hims & Hers Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$39.75 (46.73% Upside)
$39.75 (46.73% Upside)
Blogger Sentiment
Bullish
HIMS Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 2.2M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $373.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.8%
Last 30 Days ▼ 1.4%
Last 30 Days ▼ 1.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-20.22%
12-Months-Change
Fundamentals
Return on Equity
26.21%
Trailing 12-Months
Asset Growth
270.82%
Trailing 12-Months
Company Description
Hims & Hers Health, Inc.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.
HIMS Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presents a strong performance with significant revenue growth, strategic partnerships, and international expansion. However, there are challenges in gross margins and increased G&A costs. The company's strategy and future outlook remain optimistic.View all HIMS earnings summariesHIMS Revenue Breakdown
96.60% Online
3.40% Wholesale
HIMS Stock 12 Month Forecast
Average Price Target
$39.75
▲(46.73% Upside)
Technical Analysis
Ownership Overview
5.10% Insiders
25.28% Mutual Funds
0.12% Other Institutional Investors
48.83% Public Companies and Individual Investors